Review: taking Cephalexin and Carisoprodol together


Summary

Drug interactions are reported among people who take Cephalexin and Carisoprodol together. This review analyzes the effectiveness and drug interactions between Cephalexin and Carisoprodol. It is created by eHealthMe based on reports of 176 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Cephalexin and Carisoprodol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cephalexin

Cephalexin has active ingredients of cephalexin. It is often used in infection. (latest outcomes from Cephalexin 7,897 users)

Carisoprodol

Carisoprodol has active ingredients of carisoprodol. It is often used in ill-defined disorder. (latest outcomes from Carisoprodol 1,735 users)

On Jul, 29, 2016

176 people who take Cephalexin, Carisoprodol are studied.


Number of reports submitted per year:

Cephalexin and Carisoprodol drug interactions.

Drug effectiveness over time:

Cephalexin:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Carisoprodol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Cephalexin:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)
Carisoprodol:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Cephalexin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Carisoprodol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • congenital cystic kidney disease
  • single functional kidney
  • drug exposure during pregnancy
  • hydronephrosis
  • pelvi-ureteric obstruction
  • abortion spontaneous
  • anxiety
  • back pain
  • deep vein thrombosis
  • emotional distress
6 - 12 months:
  • abdominal pain
  • accelerated hypertension
  • back pain
  • cardiac murmur
  • death
  • diarrhoea
  • dizziness
  • faecal incontinence
  • fall
  • gastrooesophageal reflux disease
5 - 10 years:
  • cerebrovascular accident
  • dysarthria
  • gait disturbance
  • hypoaesthesia
  • muscular weakness
  • nausea
  • paraesthesia
  • viith nerve paralysis
  • vomiting
  • amnesia
not specified:
  • back pain
  • anxiety
  • weight decreased
  • hypoaesthesia
  • fatigue
  • dyspnoea
  • insomnia
  • headache
  • agitation
  • depression

Most common drug interactions by gender *:

female:
  • back pain
  • impaired healing
  • metastases to bone
  • osteomyelitis
  • swelling
  • arthropathy
  • osteoporosis
  • chest pain
  • osteonecrosis of jaw
  • anxiety
male:
  • anxiety
  • back pain
  • weight decreased
  • fatigue
  • headache
  • hypoaesthesia
  • insomnia
  • agitation
  • suicidal ideation
  • drug withdrawal syndrome

Most common drug interactions by age *:

0-1:
  • diabetes mellitus
  • gastritis
  • pancreatitis
20-29:
  • arthralgia
  • cellulitis
  • cold sweat
  • dizziness
  • gastrointestinal disorder
  • hyperlipidaemia
  • hypoaesthesia
  • ingrowing nail
  • menorrhagia
  • mitral valve incompetence
30-39:
  • nausea
  • insomnia
  • agitation
  • anxiety
  • drug withdrawal syndrome
  • headache
  • muscle cramp
  • tremor
  • depression
  • drug dependence
40-49:
  • back pain
  • dizziness
  • insomnia
  • headache
  • asthenia
  • depression
  • drug ineffective
  • drug withdrawal syndrome
  • hyponatraemia
  • pollakiuria
50-59:
  • injury
  • anxiety
  • back pain
  • gait disturbance
  • gastrooesophageal reflux disease
  • intervertebral disc protrusion
  • urinary tract infection
  • cough
  • depression
  • emotional distress
60+:
  • back pain
  • dyspnoea
  • deep vein thrombosis
  • impaired healing
  • metastases to bone
  • osteoarthritis
  • osteomyelitis
  • pain in extremity
  • weight decreased
  • arteriosclerosis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cephalexin and Carisoprodol?

Can you answer these questions?

More questions for: Cephalexin, Carisoprodol

You may be interested in these reviews

More reviews for: Cephalexin, Carisoprodol

On eHealthMe, Cephalexin (cephalexin) is often used to treat infection. Carisoprodol (carisoprodol) is often used to treat ill-defined disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.